CN104212833A - Novel genetically modified plasmid vector, construction method and cultivation method of silkworms containing novel recombination gene in vivo - Google Patents
Novel genetically modified plasmid vector, construction method and cultivation method of silkworms containing novel recombination gene in vivo Download PDFInfo
- Publication number
- CN104212833A CN104212833A CN201310209747.3A CN201310209747A CN104212833A CN 104212833 A CN104212833 A CN 104212833A CN 201310209747 A CN201310209747 A CN 201310209747A CN 104212833 A CN104212833 A CN 104212833A
- Authority
- CN
- China
- Prior art keywords
- silkworm
- novel
- plasmid
- vector
- transgenosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 241000255789 Bombyx mori Species 0.000 title claims abstract description 128
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 35
- 238000010276 construction Methods 0.000 title claims abstract description 10
- 239000013600 plasmid vector Substances 0.000 title claims description 22
- 238000012364 cultivation method Methods 0.000 title 1
- 238000001727 in vivo Methods 0.000 title 1
- 238000005215 recombination Methods 0.000 title 1
- 230000006798 recombination Effects 0.000 title 1
- 230000009261 transgenic effect Effects 0.000 claims abstract description 40
- 235000013601 eggs Nutrition 0.000 claims abstract description 32
- 102000002274 Matrix Metalloproteinases Human genes 0.000 claims abstract description 26
- 108010000684 Matrix Metalloproteinases Proteins 0.000 claims abstract description 26
- 238000000034 method Methods 0.000 claims abstract description 19
- 239000013598 vector Substances 0.000 claims abstract description 16
- 238000000520 microinjection Methods 0.000 claims abstract description 9
- 239000013612 plasmid Substances 0.000 claims description 35
- 241000894006 Bacteria Species 0.000 claims description 11
- 102000012410 DNA Ligases Human genes 0.000 claims description 9
- 108010061982 DNA Ligases Proteins 0.000 claims description 9
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 8
- 238000011084 recovery Methods 0.000 claims description 8
- 239000003292 glue Substances 0.000 claims description 7
- 238000012216 screening Methods 0.000 claims description 6
- 108700019146 Transgenes Proteins 0.000 claims description 5
- 238000000246 agarose gel electrophoresis Methods 0.000 claims description 5
- 238000013461 design Methods 0.000 claims description 5
- 102000004190 Enzymes Human genes 0.000 claims description 4
- 108090000790 Enzymes Proteins 0.000 claims description 4
- 230000029087 digestion Effects 0.000 claims description 4
- 238000002347 injection Methods 0.000 claims description 3
- 239000007924 injection Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 241000018646 Pinus brutia Species 0.000 claims description 2
- 101710197767 Fibroin heavy chain Proteins 0.000 claims 5
- 108091008146 restriction endonucleases Proteins 0.000 claims 3
- 210000001161 mammalian embryo Anatomy 0.000 claims 2
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims 1
- 235000011613 Pinus brutia Nutrition 0.000 claims 1
- 230000005058 diapause Effects 0.000 claims 1
- 238000011156 evaluation Methods 0.000 claims 1
- 238000001914 filtration Methods 0.000 claims 1
- 230000032696 parturition Effects 0.000 claims 1
- 239000012716 precipitator Substances 0.000 claims 1
- 230000000384 rearing effect Effects 0.000 claims 1
- 108010022355 Fibroins Proteins 0.000 abstract description 37
- 238000003776 cleavage reaction Methods 0.000 abstract description 7
- 230000007017 scission Effects 0.000 abstract description 7
- 108010043121 Green Fluorescent Proteins Proteins 0.000 abstract description 5
- 238000009395 breeding Methods 0.000 abstract description 3
- 230000001488 breeding effect Effects 0.000 abstract description 3
- 241000238631 Hexapoda Species 0.000 abstract description 2
- 238000010170 biological method Methods 0.000 abstract description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 21
- 239000000243 solution Substances 0.000 description 19
- 238000003752 polymerase chain reaction Methods 0.000 description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 16
- 238000005516 engineering process Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 11
- 239000006228 supernatant Substances 0.000 description 11
- 241000255783 Bombycidae Species 0.000 description 10
- 239000000872 buffer Substances 0.000 description 10
- 102000004169 proteins and genes Human genes 0.000 description 10
- 239000000047 product Substances 0.000 description 9
- 238000001976 enzyme digestion Methods 0.000 description 8
- 239000012634 fragment Substances 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 210000004027 cell Anatomy 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- 238000012163 sequencing technique Methods 0.000 description 7
- 239000002699 waste material Substances 0.000 description 7
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 6
- 235000008708 Morus alba Nutrition 0.000 description 6
- 240000000249 Morus alba Species 0.000 description 6
- 239000000499 gel Substances 0.000 description 6
- 230000004048 modification Effects 0.000 description 6
- 238000012986 modification Methods 0.000 description 6
- 239000002244 precipitate Substances 0.000 description 6
- 238000012546 transfer Methods 0.000 description 6
- 230000001580 bacterial effect Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 4
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 4
- 210000004899 c-terminal region Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 238000001962 electrophoresis Methods 0.000 description 4
- 210000002744 extracellular matrix Anatomy 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- 239000001110 calcium chloride Substances 0.000 description 3
- 229910001628 calcium chloride Inorganic materials 0.000 description 3
- 239000003153 chemical reaction reagent Substances 0.000 description 3
- 238000012377 drug delivery Methods 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 239000003550 marker Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 241000257303 Hymenoptera Species 0.000 description 2
- 241000382353 Pupa Species 0.000 description 2
- 239000011543 agarose gel Substances 0.000 description 2
- 230000003321 amplification Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 238000006731 degradation reaction Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000005265 energy consumption Methods 0.000 description 2
- 238000003912 environmental pollution Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 238000012215 gene cloning Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- PHTQWCKDNZKARW-UHFFFAOYSA-N isoamylol Chemical compound CC(C)CCO PHTQWCKDNZKARW-UHFFFAOYSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 238000003199 nucleic acid amplification method Methods 0.000 description 2
- 238000000053 physical method Methods 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 238000009987 spinning Methods 0.000 description 2
- 238000003860 storage Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 208000035143 Bacterial infection Diseases 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 102000006382 Ribonucleases Human genes 0.000 description 1
- 108010083644 Ribonucleases Proteins 0.000 description 1
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000012153 distilled water Substances 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 210000002257 embryonic structure Anatomy 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000011536 extraction buffer Substances 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 102000057041 human TNF Human genes 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 239000012567 medical material Substances 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 239000004005 microsphere Substances 0.000 description 1
- 239000004570 mortar (masonry) Substances 0.000 description 1
- 239000002105 nanoparticle Substances 0.000 description 1
- 239000005445 natural material Substances 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- OGJPXUAPXNRGGI-UHFFFAOYSA-N norfloxacin Chemical compound C1=C2N(CC)C=C(C(O)=O)C(=O)C2=CC(F)=C1N1CCNCC1 OGJPXUAPXNRGGI-UHFFFAOYSA-N 0.000 description 1
- 229960001180 norfloxacin Drugs 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 239000004576 sand Substances 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 239000011534 wash buffer Substances 0.000 description 1
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
本发明涉及一种新型转基因载体及其构建、体内含有新型重组基因家蚕培育方法,这种新型转基因家蚕具有一种重组的含MMP酶切位点的丝素重链蛋白基因,这项发明属于农业昆虫优良品种培育利用领域;新型转基因载体构建流程图见附图;利用MMPs酶切位点可被MMPs酶切的特点,将MMPs酶切位点引入到家蚕丝素中,使家蚕丝素具有新的性能,达到通过生物学方法对家蚕丝素改性的目的;本专利将含有MMPs酶切位点的重组丝素蛋白基因克隆到PiggyBac转座子载体上并将该载体通过显微注射的方法注入家蚕蚕卵内,蚕卵经孵化后通过选择眼睛发绿色荧光的个体确定培育成功的新型转基因家蚕。
The invention relates to a new type of transgenic carrier and its construction, and a method for cultivating silkworm containing a new recombinant gene in the body. The new type of transgenic silkworm has a recombined silk fibroin heavy chain protein gene containing an MMP enzyme cleavage site. This invention belongs to agriculture The field of breeding and utilization of fine insect varieties; the flow chart of the construction of new transgenic vectors is shown in the attached figure; using the characteristics that the MMPs restriction site can be digested by MMPs, the MMPs restriction site is introduced into the silkworm silk fibroin, so that the silkworm silk fibroin has a new performance, to achieve the purpose of modifying silkworm silk fibroin through biological methods; this patent clones the recombinant silk fibroin gene containing MMPs restriction sites into the PiggyBac transposon carrier and injects the carrier by microinjection Inside the silkworm eggs of the silkworm, after the silkworm eggs are hatched, the newly bred transgenic silkworms are determined by selecting individuals with green fluorescent eyes.
Description
技术领域technical field
本发明属于农业昆虫优良品种培育利用领域,具体涉及一种新型重组基因家蚕培育方法领域。The invention belongs to the field of cultivating and utilizing fine varieties of agricultural insects, and in particular relates to the field of a method for cultivating novel recombinant gene silkworms.
背景技术Background technique
作为一种天然材料,蚕丝在生物医学领域有着强劲的优势,如生物相容性,安全性,可降解性,良好的机械性能等。蚕丝作为医用材料有着很多的要求,也会产生一些局限,例如作为组织工程支架,它的降解速率要求和组织细胞的生长速率相一致,但是现有蚕丝不能更好地被控制在合适的时间里被降解;作为药物输送体系,药物作用部位对蚕丝本身的识别性很低,如果蚕丝具有更好的导向作用将在药物输送过程中发挥更大的作用;当蚕丝参与肿瘤等疾病的治疗过程中,作为传感器,快速的反应时间还需要进一步的探索研究。目前使用的蚕丝多为天然蚕丝,而从基因水平利用转基因技术对蚕丝蛋白进行改造,使改造后的蚕丝蛋白具有更好的生物相容性,降解性以及特有的药物输送靶向性等特性将有着很好的潜在价值。As a natural material, silk has strong advantages in the field of biomedicine, such as biocompatibility, safety, degradability, good mechanical properties, etc. As a medical material, silk has many requirements and also has some limitations. For example, as a tissue engineering scaffold, its degradation rate is required to be consistent with the growth rate of tissue cells, but the existing silk cannot be better controlled in a suitable time. degraded; as a drug delivery system, the identification of the drug action site on silk itself is very low, if silk has a better guiding effect, it will play a greater role in the drug delivery process; when silk participates in the treatment of tumors and other diseases , as a sensor, the fast response time needs to be further explored. Most of the silk currently used is natural silk, and the modification of silk protein by transgenic technology at the genetic level will make the modified silk protein have better biocompatibility, degradability and unique drug delivery targeting properties. Has good potential value.
基质金属蛋白酶(matrix metalloproteinases,MMPs)是降解细胞外基质(extra-cellularmatrix,ECM)的最重要的酶系,占ECM降解酶总活性的70%以上,MMPs的活化被认为是ECM降解的限速环节。利用MMPs酶切位点可被MMPs酶切的特点,已有相关技术创新出现,如黄迪南等的发明专利:基质金属蛋白酶导向性重组人肿瘤坏死因子融合蛋白及制备(专利申请号:2007100280375)。但目前还没有关于将MMPs酶切位点引入重组丝素重链蛋白,构建新型家蚕丝素的报导。目前对家蚕丝素改性的方法有物理方法,如将蚕丝制成微球/纳米颗粒等,但物理方法改性不能改变丝素的生物化学特性。也有化学方法,如丝素蛋白的接枝改性等。化学方法对家蚕丝素进行加工改性,需要消耗更多的能源,甚至造成环境污染。Matrix metalloproteinases (MMPs) are the most important enzyme system for degrading the extracellular matrix (ECM), accounting for more than 70% of the total activity of ECM degrading enzymes, and the activation of MMPs is considered to be the rate-limiting rate of ECM degradation. link. Utilizing the feature that MMPs cleavage sites can be cleaved by MMPs, relevant technological innovations have appeared, such as the invention patent of Huang Dinan et al.: matrix metalloproteinase-directed recombinant human tumor necrosis factor fusion protein and its preparation (patent application number: 2007100280375). But there is no report about introducing MMPs restriction sites into recombinant silk fibroin heavy chain protein to construct a new type of silk fibroin. At present, there are physical methods for modifying silk fibroin, such as making silk into microspheres/nanoparticles, etc., but physical modification cannot change the biochemical properties of silk fibroin. There are also chemical methods, such as graft modification of silk fibroin, etc. The processing and modification of silkworm silk fibroin by chemical methods will consume more energy and even cause environmental pollution.
发明内容Contents of the invention
本发明的目的在于培育一种新型转基因家蚕,这种新型转基因家蚕具有一种重组的丝素重链蛋白基因,并且这种重组丝素重链蛋白含有MMP酶切位点,解决化学方法耗能多,环境污染问题,物理方法不能改变丝素的生物化学特性问题The purpose of the present invention is to breed a new type of transgenic silkworm, which has a recombined silk fibroin heavy chain protein gene, and this recombined silk fibroin heavy chain protein contains an MMP enzyme cleavage site, which solves the problem of energy consumption of chemical methods. Many, environmental pollution problems, physical methods can not change the biochemical properties of silk fibroin
发明技术方案:本专利将MMP酶切位点引入到重组丝素重链蛋白基因中,构建一种新型家蚕转基因质粒载体,并将这种新型载体采用显微注射法注入到产下一定时间内的蚕卵中,通过观察蚕蛾眼部的荧光现象鉴定转基因是否成功,培育一种新型转基因家蚕,这种新型转基因家蚕的培育方法将成为用生物学方法改造家蚕丝素,使家蚕丝素蛋白具有MMP酶切位点的基础技术,达到丝素改性的目的。Technical solution of the invention: This patent introduces the MMP enzyme cleavage site into the recombinant silk fibroin heavy chain protein gene, constructs a new type of silkworm transgenic plasmid vector, and injects this new type of vector into the production within a certain period of time by microinjection. In the silkworm eggs, by observing the fluorescence phenomenon of the moth's eyes to identify whether the transgene is successful, a new type of transgenic silkworm is bred. The basic technology of MMP enzyme cleavage site achieves the purpose of silk fibroin modification.
本发明第1个目的是采用基因克隆技术构建一种新型家蚕转基因质粒载体,这种质粒载体具有一种重组的丝素重链蛋白基因,并且这种重组丝素重链蛋白含有MMP酶切位点,通过以下方案实现:The first purpose of the present invention is to use gene cloning technology to construct a novel silkworm transgenic plasmid vector, which has a recombined silk fibroin heavy chain protein gene, and this recombined silk fibroin heavy chain protein contains an MMP enzyme cleavage site point, achieved through the following schemes:
首先采用乙醇沉淀法提取家蚕(菁松)基因组,然后利用设计的引物PCR扩增出家蚕重链N端和C端基因序列片段,接着运用pMD-18T simple载体连接技术,PCR技术,酶切技术,T4DNA连接酶技术构建新型家蚕转基因质粒载体(构建流程图见图1)。First, the silkworm (Jingsong) genome was extracted by ethanol precipitation, and then the N-terminal and C-terminal gene sequence fragments of the heavy chain of the silkworm were amplified by PCR with the designed primers, and then the pMD-18T simple vector ligation technology, PCR technology, and enzyme digestion technology were used , T4 DNA ligase technology to construct a new silkworm transgenic plasmid vector (see Figure 1 for the construction flow chart).
本发明第2个目的是将已构建的新型家蚕转基因质粒载体采用显微注射法注入到产下一定时间内的蚕卵中,通过观察蚕蛾眼部的荧光现象鉴定转基因是否成功,培育一种新型转基因家蚕,这种家蚕基因组具有一种重组的丝素重链蛋白基因,并且这种重组丝素重链蛋白含有MMP酶切位点,通过以下方案实现:The second purpose of the present invention is to inject the constructed novel silkworm transgenic plasmid carrier into the silkworm eggs laid within a certain period of time by microinjection, and to identify whether the transgene is successful by observing the fluorescence phenomenon in the eyes of the silkworm moth, and to cultivate a new type of silkworm. The transgenic silkworm, the silkworm genome has a recombinant silk fibroin heavy chain protein gene, and this recombinant silk fibroin heavy chain protein contains an MMP enzyme cleavage site, which is achieved by the following scheme:
首先将已构建的新型家蚕转基因质粒载体pBac[3×P3-EGFPafm]-FibH-GS-site与Piggybac Help Plasmid进行等量混合,采用显微注射法将混合质粒注入产下一定时间内的蚕卵中。通过观察后代蚕蛾眼部的荧光现象鉴定转基因是否成功,并通过基因组PCR法及测序鉴定获得新型转基因家蚕。Firstly, the newly constructed silkworm transgenic plasmid vector pBac[3×P3-EGFPafm]-FibH-GS-site and Piggybac Help Plasmid were mixed in equal amounts, and the mixed plasmid was injected into silkworm eggs laid within a certain period of time by microinjection. middle. The success of the transgene was identified by observing the fluorescence phenomenon of the eyes of the offspring silkworm moths, and a new type of transgenic silkworm was obtained through genomic PCR and sequencing identification.
本发明的有益效果是:The beneficial effects of the present invention are:
1、本发明提供的技术中将家蚕(菁松)基因组中丝素重链的N端和C端基因以及基质金属蛋白酶的酶切位点基因序列克隆进piggyBac载体中,采用显微注射的方法进行家蚕蚕卵的转基因,达到了培育一种新型转基因家蚕的效果。这种新型转基因家蚕具有一种重组的丝素重链蛋白基因,并且这种重组丝素重链蛋白含有MMP酶切位点。1. In the technology provided by the present invention, the N-terminal and C-terminal genes of the silk fibroin heavy chain in the silkworm (Pine pine) genome and the restriction site gene sequence of matrix metalloproteinase are cloned into the piggyBac vector, and the method of microinjection is adopted The transgenic silkworm eggs have achieved the effect of cultivating a new type of transgenic silkworm. The novel transgenic silkworm has a recombined silk fibroin heavy chain protein gene, and the recombined silk fibroin heavy chain protein contains an MMP restriction site.
2、本发明提供的技术中将眼特异启动子3×P3启动子调控下转录的绿色荧光蛋白基因置于piggyBac载体中与重组丝素重链蛋白基因一同转入家蚕蚕卵中。达到了直观分离培育成功的新型转基因家蚕的效果。2. In the technology provided by the present invention, the green fluorescent protein gene transcribed under the control of the eye-specific promoter 3×P3 promoter is placed in the piggyBac vector and transferred into silkworm eggs together with the recombinant silk fibroin heavy chain protein gene. The effect of intuitively separating and cultivating the successful novel transgenic silkworm has been achieved.
3、生物学方法改造家蚕丝素,可减少丝素产品加工的步骤,从而减少能源的消耗。3. Modification of silkworm silk fibroin by biological methods can reduce the steps of silk fibroin product processing, thereby reducing energy consumption.
附图说明Description of drawings
图1用于构建一种新型家蚕转基因质粒载体的流程图Fig. 1 is used to construct the flowchart of a kind of novel silkworm transgenic plasmid vector
图2新型家蚕转基因质粒载体的PCR验证Figure 2 PCR verification of the new silkworm transgenic plasmid vector
图3体视显微镜下观察对照组和实验组蚕蛾Figure 3 Observation of silk moths in the control group and the experimental group under a stereo microscope
图4PCR扩增检测转基因蚕蛾基因组Figure 4PCR amplification detection transgenic silk moth genome
图5转基因蚕蛾基因组中片段Fib H-GS-site的测序结果。Fig. 5 Sequencing results of the fragment Fib H-GS-site in the genome of the transgenic silkworm moth.
具体实施方式Detailed ways
本发明结合具体实施例作进一步说明。应理解,这些实施例仅用于说明目的,而不用于限制本发明范围。The present invention will be further described in conjunction with specific embodiments. It should be understood that these examples are for illustrative purposes only and are not intended to limit the scope of the invention.
实施例1Example 1
本发明采用基因克隆技术构建一种新型家蚕转基因质粒载体,这种质粒载体具有一种重组的丝素重链蛋白基因,并且这种重组丝素重链蛋白含有MMP酶切位点。具体步骤如下:The invention adopts gene cloning technology to construct a novel silkworm transgenic plasmid carrier, the plasmid carrier has a recombined silk fibroin heavy chain protein gene, and the recombined silk fibroin heavy chain protein contains an MMP restriction site. Specific steps are as follows:
1,设计新型家蚕转基因质粒载体构建流程1. Design a new silkworm transgenic plasmid vector construction process
设计用于构建一种新型家蚕转基因质粒载体的流程,见图1。其中fibroin H指丝素重链基因,PCR指聚合酶链式反应技术,FibH-N指丝素重链蛋白N端基因序列,A,B,F分别指Asc I,BamH I,Fse I酶切位点,pMD-FibH-N指克隆有FibH-N的pMD-18T simple载体(购于Takara公司),FibH-GS-site-C指带有MMPs酶切位点的丝素重链蛋白C端基因序列。The flow chart designed to construct a novel silkworm transgenic plasmid vector is shown in Figure 1. Among them, fibroin H refers to silk fibroin heavy chain gene, PCR refers to polymerase chain reaction technology, FibH-N refers to silk fibroin heavy chain protein N-terminal gene sequence, A, B, F refer to Asc I, BamH I, Fse I enzyme digestion site, pMD-FibH-N refers to the pMD-18T simple vector with FibH-N cloned (purchased from Takara Company), and FibH-GS-site-C refers to the C-terminus of silk fibroin heavy chain protein with MMPs restriction site gene sequence.
2,家蚕(菁松)基因组提取2. Genome Extraction of Bombyx mori (Jingsong Song)
取家蚕(菁松)5龄三天蚕的中肠,放入预冷的研钵中,加入液氮快速研磨成粉状;将粉末刮入1.5ml EP管中,加入抽提缓冲液(10Mm Tris-Cl(PH8.0),0.1M EDTA(PH8.0),0.5%SDS)700μl,室温放置1h,再加入蛋白酶K至终浓度为500μg/mL,同时加入RNase至终浓度为50μg/ml,放置于56℃水浴锅中水浴5h(每隔1h摇晃一次);取出消化后的样品,加入等体积苯酚,摇匀后,12000rpm离心10min,取上清650μl至新的1.5ml EP管中;加入等体积的酚/氯仿/异戊醇(25:24:1),摇匀后,12000rpm离心10min,取上清600μl至新的1.5ml EP管中;加入等体积的酚/氯仿(1:1),摇匀后,12000rpm离心10min,取上清550μl至新的1.5ml EP管中;加入等体积的氯仿,摇匀后,12000rpm离心10min,取上清500μl至新的1.5ml EP管中;加入900μl预冷的无水乙醇,再加入100μl3M NaAC(PH5.2),置于-20℃冰箱中冰冻15min;12000rpm离心10min,沉淀DNA,弃上清;用1ml70%冰乙醇洗涤沉淀2次,然后尽量弃上清,自然晾干,使乙醇挥发殆尽;加入40μl dd H2O灭菌dd H2O,溶解沉淀2h或者4℃过夜,-20℃保存备用。Take the midgut of the 5th instar three-day-old silkworm (Jingsong), put it into a pre-cooled mortar, add liquid nitrogen and quickly grind it into powder; scrape the powder into a 1.5ml EP tube, add extraction buffer (10Mm Tris -Cl (PH8.0), 0.1M EDTA (PH8.0), 0.5% SDS) 700μl, place at room temperature for 1h, then add proteinase K to a final concentration of 500μg/mL, and add RNase to a final concentration of 50μg/ml, Place in a water bath at 56°C for 5 hours (shake every 1 hour); take out the digested sample, add an equal volume of phenol, shake well, centrifuge at 12,000 rpm for 10 minutes, take 650 μl of the supernatant into a new 1.5ml EP tube; add Equal volume of phenol/chloroform/isoamyl alcohol (25:24:1), shake well, centrifuge at 12000rpm for 10min, take 600μl of the supernatant into a new 1.5ml EP tube; add an equal volume of phenol/chloroform (1:1 ), shake well, centrifuge at 12000rpm for 10min, take 550μl of the supernatant into a new 1.5ml EP tube; add an equal volume of chloroform, shake well, centrifuge at 12000rpm for 10min, take 500μl of the supernatant into a new 1.5ml EP tube; Add 900 μl of pre-cooled absolute ethanol, then add 100 μl of 3M NaAC (PH5.2), freeze in a -20°C refrigerator for 15 min; centrifuge at 12,000 rpm for 10 min, precipitate DNA, and discard the supernatant; wash the precipitate twice with 1 ml of 70% ice ethanol, Then discard the supernatant as much as possible, dry it naturally to evaporate the ethanol; add 40 μl dd H2O to sterilize dd H2O, dissolve the precipitate for 2 hours or overnight at 4°C, and store it at -20°C for later use.
3,聚合酶链式反应(PCR)扩增丝素重链蛋白基因目的序列3. Polymerase chain reaction (PCR) amplification of the target sequence of silk fibroin heavy chain protein gene
(1)引物设计(1) Primer design
以家蚕(菁松)基因组为模板,利用Primer Premier5.0设计以下引物:Using the silkworm (Jingsong) genome as a template, use Primer Premier5.0 to design the following primers:
其中Fib-H-p1和Fib-H-p2是用来扩增家蚕丝素重链N端基因的引物对,Fib-H-p1和Fib-H-p2分别为上游引物和下游引物。Big-o-p3和Fib-H-p4是用来扩增家蚕丝素重链C端基因的引物对,Big-o-p3和Fib-H-p4分别为上游引物和下游引物,Big-o-p3引物中含有MMPs酶切位点序列。Wherein Fib-H-p1 and Fib-H-p2 are primer pairs used to amplify silk fibroin heavy chain N-terminal gene, and Fib-H-p1 and Fib-H-p2 are upstream primers and downstream primers respectively. Big-o-p3 and Fib-H-p4 are primer pairs used to amplify the C-terminal gene of silk fibroin heavy chain, Big-o-p3 and Fib-H-p4 are upstream primers and downstream primers respectively, Big-o -The p3 primer contains the MMPs restriction site sequence.
(2)PCR扩增:利用设计的引物对提取的家蚕基因组进行PCR扩增获得家蚕丝素重链N端和C端基因序列片段。PCR扩增体系如下:(2) PCR amplification: PCR amplification was carried out on the extracted silkworm genome using the designed primers to obtain the N-terminal and C-terminal gene sequence fragments of silk fibroin heavy chain. The PCR amplification system is as follows:
PCR条件:94℃5min;94℃30s;56℃30s;72℃1min/1kb;72℃10min;12℃forever。PCR conditions: 94°C for 5min; 94°C for 30s; 56°C for 30s; 72°C for 1min/1kb; 72°C for 10min; 12°C forever.
4,构建新型家蚕转基因质粒载体4. Construction of a new silkworm transgenic plasmid vector
(1)将引物Fib-H-p1和Fib-H-p2的PCR产物直接连接至pMD-18T simple 载体中,构建质粒pMD-FibH-N,反应体系为:体系:solution I5μl;(1) The PCR products of primers Fib-H-p1 and Fib-H-p2 were directly connected to the pMD-18T simple vector to construct the plasmid pMD-FibH-N, and the reaction system was: system: solution I5μl;
目的片段4.5μl;Target fragment 4.5μl;
simpleT-180.5μl;simpleT-180.5μl;
条件:16℃连接1-2hConditions: 16°C connection for 1-2h
(2)制备感受态细胞(氯化钙法)(2) Preparation of competent cells (calcium chloride method)
从培养菌的平板上挑取单克隆点,转接到两根含3-5mlLB培养基的试管中,37℃摇床210rpm摇菌12-16h;将两管培养菌分别制备15%甘油菌(425μl的菌液+75μl的甘油,甘油需要预先灭菌后4度保存),-70℃保存;从1号试管中取出200μl加到200ml的LB培养基中,37℃摇床210rpm摇菌约6h,摇至OD值为0.498,在无菌超净台上将培养菌分装到6管无菌预冷的40ml离心管中,每管30ml,冰上放置10min;4℃,4000rpm,10min离心,超净台上倒掉培养液,并倒置在滤纸上,将培养液去除干净后盖好放在冰上;每管加1ml0.1MMgCl2,混于一管,冰浴20min,4000rpm,10min离心;超净台上倒掉培养液,并倒置在滤纸上,将培养液去除干净后盖好放在冰上;加6ml0.05M冰冷氯化钙(高温灭菌后-20℃保存),将沉淀轻慢打匀,轻轻放置于冰上30min;4℃,4000rpm,10min离心,超净台上倒掉培养液,并倒置在滤纸上1min,将培养液去除干净后盖好放在冰上;加2ml0.1M冰冷氯化钙,再加入1ml50%甘油(终浓度15%),将沉淀轻慢打匀,冰浴;尽快将感受态菌液分装到EP管中,快速封口,每管200μl,-70℃保存。Pick a single colony point from the plate of the cultured bacteria, transfer it to two test tubes containing 3-5ml LB medium, and shake the bacteria at 210rpm on a 37°C shaker for 12-16h; prepare 15% glycerol bacteria from the two tubes of cultured bacteria ( 425 μl of bacterial solution + 75 μl of glycerol (glycerol needs to be pre-sterilized and stored at 4 degrees), stored at -70°C; take 200 μl from No. 1 test tube and add it to 200ml of LB medium, shake the bacteria at 210rpm at 37°C for about 6 hours , shake until the OD value is 0.498, divide the culture into 6 tubes of sterile pre-cooled 40ml centrifuge tubes on a sterile ultra-clean bench, 30ml per tube, place on ice for 10min; 4°C, 4000rpm, 10min centrifugation, Pour off the culture solution on the ultra-clean platform, and invert it on the filter paper, remove the culture solution, cover it and put it on ice; add 1ml0.1MMgCl2 to each tube, mix in one tube, ice bath for 20min, 4000rpm, and centrifuge for 10min; Pour off the culture medium on the clean platform, and invert it on the filter paper, remove the culture medium, cover it and put it on ice; add 6ml of 0.05M ice-cold calcium chloride (after high-temperature sterilization and store at -20°C), and shake the precipitate gently Gently place on ice for 30min; 4°C, 4000rpm, centrifuge for 10min, pour off the culture medium on the ultra-clean platform, and invert it on the filter paper for 1min, remove the culture medium, cover it and put it on ice; add 2ml0. 1M ice-cold calcium chloride, then add 1ml 50% glycerol (final concentration 15%), mix the precipitate gently, and put it in an ice bath; divide the competent bacterial solution into EP tubes as soon as possible, quickly seal, 200μl per tube, -70℃ save.
(3)转化、存菌(3) Transformation and storage of bacteria
从-70℃冰箱中取出感受态细胞,冰浴至融化,一种连接产物转化一支感受态细胞,并留1支感受态做阴性对照,将连接产物10ul加入感受态细胞,冰上放置5-10min,42℃热激90s(勿动),迅速转至冰上放置1-2min,无菌超净台上分别加入LB培养基800μl;37℃,210rpm,摇菌45min,使细胞复苏,3000rpm,离心4min;超净台中操作以下步骤:分别弃上清800μl,剩余的将沉淀打匀,分别涂平板;37℃恒温培养箱培养12-18h,观察菌落情况;挑单斑用试管(4ml LB培养基,加有抗生素),37℃,210rpm,摇菌14h,PCR验证正确后甘油菌存菌(甘油15-30%,菌液85-70%),甘油菌标记,于-70℃保存。Take out the competent cells from the refrigerator at -70°C, bathe in ice until they melt, transform one competent cell with one ligation product, and keep one competent cell as a negative control, add 10ul of the ligation product to the competent cells, and place on ice for 5 -10min, heat shock at 42°C for 90s (do not move), quickly transfer to ice and place for 1-2min, add 800μl of LB medium on a sterile ultra-clean table; , Centrifuge for 4min; operate the following steps in the ultra-clean platform: Discard 800μl of the supernatant respectively, mix the remaining precipitates evenly, and spread them on the plates respectively; incubate in a constant temperature incubator at 37°C for 12-18h, and observe the colonies; use a test tube (4ml LB Culture medium, with antibiotics), 37°C, 210rpm, shaking for 14 hours, after PCR verification, glycerol bacteria were stored (15-30% glycerol, 85-70% bacterial liquid), labeled with glycerol bacteria, and stored at -70°C.
(4)质粒提取(4) Plasmid extraction
按质粒提取试剂盒说明书操作,取1-2ml过夜培养的菌液,12000rpm离心1min,弃尽上清,加入200μl Solution I,用枪头或者振荡器充分悬浮细菌;加入200μl Solution II,立即温和并充分地上下翻转混合4-6次,使菌体充分裂解,直至形成透亮的蛋清状溶液,此步骤不宜超过5min。加入350μl Solution III,温和充分地上下翻转混合8-10次,室温放置2-5min,12000rpm,离心10min。将上清转移到套放于2ml收集管内的GenClean Column中,室温6000rpm离心1min,取出GenClean Column,倒掉收集管中的废液。将GenClean Column重新放回收集管中,加入500μl Solution IV,12000rpm,室温离心1min,倒掉收集管中废液。将GenClean Cloumn重新放回收集管中,加入500μl Wash Solution,12000rpm,室温离心1min,倒掉收集管中废液。重复一次。倒掉收集管中废液,12000rpm,室温离心1min,彻底去除WashSolution。将GenClean Column放入干净的1.5ml离心管中,在GenClean Cloumn膜中央加入50μl-70μl的Elution Buffer,37℃放置2min。12000rpm,室温离心1min,离心管中的液体即为包含目的质粒的溶液,取2-5μl进行琼脂糖凝胶电泳检测,纯化好的DNA可立即用于后续实验或-20℃冻存。Operate according to the instructions of the plasmid extraction kit, take 1-2ml of overnight cultured bacterial solution, centrifuge at 12000rpm for 1min, discard the supernatant, add 200μl Solution I, fully suspend the bacteria with a pipette tip or a shaker; add 200μl Solution II, immediately gently and Fully turn up and down and mix 4-6 times to fully lyse the bacteria until a clear egg white-like solution is formed. This step should not exceed 5 minutes. Add 350μl Solution III, gently and thoroughly mix up and down 8-10 times, place at room temperature for 2-5min, centrifuge at 12000rpm for 10min. Transfer the supernatant to a GenClean Column set in a 2ml collection tube, centrifuge at 6000rpm for 1min at room temperature, take out the GenClean Column, and discard the waste liquid in the collection tube. Put the GenClean Column back into the collection tube, add 500 μl Solution IV, centrifuge at 12000 rpm for 1 min at room temperature, and discard the waste liquid in the collection tube. Put the GenClean Cloumn back into the collection tube, add 500μl Wash Solution, centrifuge at 12000rpm, room temperature for 1min, and discard the waste liquid in the collection tube. repeat. Pour off the waste liquid in the collection tube, centrifuge at 12000rpm at room temperature for 1min, and completely remove the WashSolution. Put the GenClean Column into a clean 1.5ml centrifuge tube, add 50μl-70μl of Elution Buffer to the center of the GenClean Cloumn membrane, and place it at 37°C for 2min. Centrifuge at 12000rpm at room temperature for 1min. The liquid in the centrifuge tube is the solution containing the target plasmid. Take 2-5μl for agarose gel electrophoresis detection. The purified DNA can be used immediately for subsequent experiments or frozen at -20°C.
(5)DNA的琼脂糖凝胶电泳及胶回收(5) DNA agarose gel electrophoresis and gel recovery
电泳条件:Electrophoresis conditions:
配制1%的琼脂糖凝胶,250bp DNA Marker,电压120V,恒压电泳。Prepare 1% agarose gel, 250bp DNA Marker, voltage 120V, constant voltage electrophoresis.
胶回收步骤:Glue recovery steps:
按照琼脂糖凝胶回收试剂盒说明书操作,按照电泳条件估算回收后样品浓度。Operate according to the instructions of the agarose gel recovery kit, and estimate the concentration of the recovered sample according to the electrophoresis conditions.
(6)对提取好的质粒pMD-FibH-N和经琼脂糖凝胶电泳及胶回收的PCR产物FibH-GS-site-C进行双酶切,酶切体系如下:(6) Perform double enzyme digestion on the extracted plasmid pMD-FibH-N and the PCR product FibH-GS-site-C recovered by agarose gel electrophoresis and gel recovery. The enzyme digestion system is as follows:
酶切条件:37℃,酶切3-5h。Digestion conditions: 37°C, 3-5h.
酶切后胶回收FibH-N序列和FibH-GS-site-C序列。并用T4 DNA ligase连接。After enzyme digestion, the FibH-N sequence and FibH-GS-site-C sequence were recovered from the gel. And ligated with T4 DNA ligase.
连接体系如下:The connection system is as follows:
体系:片段的摩尔比1:1;FibH-N序列和FibH-GS-site-C序列各4μl。System: The molar ratio of fragments is 1:1; FibH-N sequence and FibH-GS-site-C sequence are each 4 μl.
T4 DNA ligase 1μl;T4 DNA ligase 1μl;
T4 DNA ligase buffer 1μlT4 DNA ligase buffer 1μl
条件:16℃连接14-20hCondition: 16°C connection 14-20h
(7)第6步连接产物胶回收后以引物对(Fib-H-p1和Fib-H-p4)PCR扩增含MMPs酶切位点的重组丝素重链蛋白基因。(7) After the gel recovery of the ligation product in step 6, use the primer pair (Fib-H-p1 and Fib-H-p4) to PCR amplify the recombinant silk fibroin heavy chain protein gene containing the MMPs restriction site.
(8)对第7步PCR产物的胶回收产物和转基因载体质粒pBac[3×P3-EGFPafm]进行双酶切,酶切体系如下:(8) Perform double enzyme digestion on the gel recovery product of the PCR product in step 7 and the transgenic vector plasmid pBac[3×P3-EGFPafm]. The enzyme digestion system is as follows:
酶切条件:37℃,酶切3-5h。Digestion conditions: 37°C, 3-5h.
(9)酶切后胶回收目的序列。并用T4 DNA ligase连接,构建新型家蚕转基因质粒载体,并将连接产物转化至感受态细胞中。(9) Retrieve the target sequence by gel after enzyme digestion. T4 DNA ligase was used to connect to construct a new silkworm transgenic plasmid vector, and the ligated product was transformed into competent cells.
连接体系如下:The connection system is as follows:
体系:片段和载体的摩尔比3-8:1;System: The molar ratio of fragment and carrier is 3-8:1;
T4 DNA ligase 1μl;T4 DNA ligase 1μl;
T4 DNA ligase buffer 1μlT4 DNA ligase buffer 1μl
条件:16℃连接14-20hCondition: 16°C connection 14-20h
5,新型家蚕转基因质粒载体的PCR验证5. PCR verification of the new silkworm transgenic plasmid vector
利用引物Fib-H-p1和Fib-H-p4对质粒pBac[3×P3-EGFPafm ]-Fib H-GS-site进行PCR验证,电泳结果见图2。其中M指250bp DNA标准分子量Marker,GS指片段Fib H-GS-site;数字为分子量大小,单位为bp。The plasmid pBac[3×P3-EGFPafm ]-Fib H-GS-site was verified by PCR using primers Fib-H-p1 and Fib-H-p4, and the electrophoresis results are shown in Figure 2. Among them, M refers to the 250bp DNA standard molecular weight Marker, and GS refers to the fragment Fib H-GS-site; the number is the molecular weight, and the unit is bp.
实施例2Example 2
本发明将已构建的新型家蚕转基因质粒载体pBac[3×P3-EGFPafm]-FibH-GS-site与Piggybac Help Plasmid进行等量混合,采用显微注射法将混合质粒注入产下一定时间内的蚕卵中。由于在转基因载体中采用了3×P3启动子,通过观察蚕蛾眼部的荧光现象鉴定转基因是否成功,并通过基因组PCR法及测序鉴定获得的转基因家蚕。具体步骤如下:In the present invention, the constructed novel silkworm transgenic plasmid vector pBac[3×P3-EGFPafm]-FibH-GS-site is mixed with Piggybac Help Plasmid in equal amounts, and the mixed plasmid is injected into silkworms that have been born for a certain period of time by microinjection. in the egg. Since the 3×P3 promoter is used in the transgenic vector, the success of the transgene is identified by observing the fluorescence phenomenon in the eyes of the silkworm moth, and the obtained transgenic silkworm is identified by genome PCR and sequencing. Specific steps are as follows:
1质粒提取1 plasmid extraction
质粒提取采用试剂盒QIAprep Spin Miniprep Kit(货号:27104),严格按照质粒提取试剂盒说明书操作。(注意:将LyseBlue reagent 加到Buffer P1中。将试剂盒中带有的RNase A溶液加到Buffer P1中,混合,2-8℃存放P1。使用Buffer PE时,将无水乙醇加入到PE中。所有的离心条件都是13000rpm。)The plasmid was extracted using the kit QIAprep Spin Miniprep Kit (Cat. No.: 27104), and the operation was strictly in accordance with the instructions of the plasmid extraction kit. (Note: Add LyseBlue reagent to Buffer P1. Add the RNase A solution included in the kit to Buffer P1, mix, and store P1 at 2-8°C. When using Buffer PE, add absolute ethanol to PE .All centrifugation conditions are 13000rpm.)
收集1-5ml过夜培养的菌液,10000rpm,室温离心3min;弃尽上清,用250μl Buffer P1悬浮沉淀并转移到一个微量离心管中;加250μl Buffer P2,旋转离心管4-6次,直至溶液变得澄清,如果Buffer P1加入了蓝色试剂,溶液变成清亮的蓝色。这一步反应不要超过5min;加入350μl Buffer N3,立即旋转离心管4-6次,如果Buffer P1加入了蓝色试剂,溶液变成无色;13000rpm,室温离心10min。取出上清转于QIAprep spin column中,室温离心1min,弃掉废液;用500μl Buffer PB洗QIAprep spin column,室温离心1min,弃掉废液;加入750μlBuffer PE洗QIAprep spin column,室温离心1min,弃掉废液;室温离心1min取出残留的washbuffer;将QIAprep column放在一个干净的离心管上面,加入50μl Buffer EB,室温放置1min,离心1min。Collect 1-5ml of overnight cultured bacterial solution, centrifuge at 10000rpm for 3min at room temperature; discard the supernatant, suspend the pellet with 250μl Buffer P1 and transfer to a microcentrifuge tube; add 250μl Buffer P2, and rotate the centrifuge tube 4-6 times until The solution becomes clear, and if Buffer P1 is added with a blue reagent, the solution becomes clear blue. The reaction in this step should not exceed 5 minutes; add 350 μl Buffer N3, and immediately rotate the centrifuge tube 4-6 times, if Buffer P1 is added with a blue reagent, the solution becomes colorless; centrifuge at 13000 rpm for 10 minutes at room temperature. Take out the supernatant and transfer it to the QIAprep spin column, centrifuge at room temperature for 1 min, discard the waste liquid; wash the QIAprep spin column with 500 μl Buffer PB, centrifuge at room temperature for 1 min, discard the waste liquid; add 750 μl Buffer PE to wash the QIAprep spin column, centrifuge at room temperature for 1 min, discard Remove the waste liquid; centrifuge at room temperature for 1 min to remove the remaining washbuffer; put the QIAprep column on a clean centrifuge tube, add 50 μl Buffer EB, place at room temperature for 1 min, and centrifuge for 1 min.
2显微注射2 Microinjection
(1)将分别含有目的基因的载体pBac[3×P3-EGFPafm]-FibH-GS-site和Piggybac Help质粒的大肠杆菌菌株接种到5ml新鲜的LB培养基中,培养14h,按照QIAGEN Plasimd MiniKit质粒抽提试剂盒说明书所述操作步骤提取超纯质粒,用One-Drop测定质粒浓度后置于-20℃备用;(1) Inoculate the Escherichia coli strains containing the vector pBac[3×P3-EGFPafm]-FibH-GS-site and Piggybac Help plasmids of the target gene into 5ml of fresh LB medium, culture for 14h, and follow the QIAGEN Plasimd MiniKit plasmid Extract the ultrapure plasmid through the operation steps described in the manual of the extraction kit, measure the concentration of the plasmid with One-Drop, and store it at -20°C for later use;
(2)将生粉配制成60%重量比的水剂,蒸成糨糊状,均匀涂抹于蚕连纸上,自然晾干;(2) Prepare raw powder into 60% water by weight, steam it into a paste, apply it evenly on the silkworm paper, and let it dry naturally;
(3)将交配后的雌蛾投放于上浆的蚕连纸上,在黑暗的环境中产卵,每间隔40min收集一次蚕卵,并将雌蛾移至另一蚕连纸上继续产卵,直至产卵完毕;(3) Put the mated female moths on the starched silkworm paper, lay eggs in a dark environment, collect silkworm eggs every 40 minutes, and move the female moths to another silkworm paper to continue laying eggs, until spawning is complete;
(4)将收集的蚕卵连同蚕连纸片在25℃左右的单蒸水中浸泡1min,待蚕连纸上的浆糊浸润以后用细毛笔将蚕卵转移至用75%酒精消毒的载玻片上,用细毛笔将蚕卵逐颗整齐排列于载玻片上,将蚕卵固定于载玻片上,蚕卵卵孔部位朝上,卵窝部位朝右,自然晾干;(4) Soak the collected silkworm eggs and silkworm paper in single distilled water at about 25°C for 1 min. After the paste on the silkworm paper is infiltrated, use a fine brush to transfer the silkworm eggs to a glass slide sterilized with 75% alcohol. On the slide, neatly arrange the silkworm eggs one by one on the glass slide with a fine brush, fix the silkworm eggs on the slide, with the hole of the silkworm egg facing upwards and the egg fossa facing the right, and let it dry naturally;
(5)将重组质粒与Helper质粒混合液用注射缓冲液调整浓度为约0.4μg/μl,按1∶1的体积比例,注射到非滞育的早期胚胎中,时间是产卵后1~3h,注射量为15-20ng(10-15nl)DNA;(5) Adjust the concentration of the recombinant plasmid and Helper plasmid mixture to about 0.4 μg/μl with injection buffer, and inject it into non-diapausing early embryos at a volume ratio of 1:1, and the time is 1 to 3 hours after oviposition , the injection volume is 15-20ng (10-15nl) DNA;
(6)用甲醛蒸气消毒处理后,置于25℃、相对湿度95%-100%的条件下进行催青。(6) After being sterilized with formaldehyde vapor, it is placed under the conditions of 25°C and relative humidity of 95%-100% for greening.
3家蚕饲育3 silkworm breeding
催青期蚕卵每隔2-3天进行一次甲醛蒸汽消毒,每天都要保证蚕卵所处环境相对湿度为95%-100%,转青后要黑暗处理,保证出蚁一致,便于饲养。收取蚕蚁,蚕蚁用最嫩的桑叶弄碎喂食,每天喂食4次,2-3天后眠;蜕皮后为二龄,相应的桑叶最好还是最嫩叶子,每天可以开始加网除蚕沙,每天喂食3-4次,再喂养3-4天后眠;蜕皮后为三龄,相应的喂食的桑叶为嫩叶,大小为蚕体的1-2倍,每天喂食3次,除沙1次,这之前的蚕室温度最好为26-27℃,相对湿度为85-90%,此时如果每框蚕的数量过多,可以分框饲养,小框每框保证80-100只,4-5天后眠;蜕皮后为四龄,相应喂食的桑叶为大叶,大小为蚕体的2倍,每天喂食3次,清理蚕粪便等2次,此时如果环境不适,或者为了防止细菌等感染,可以开始采用在桑叶上喷洒诺氟沙星(50μg/ml),温度为25℃左右,相对湿度85%左右,5-6天后眠;蜕皮后为五龄,相应的喂食可以慢慢变化为老叶子,大小为蚕体的2倍,温度为25℃左右,相对湿度为80-85%,每天喂食3-4天,近结茧前,需要大量喂食桑叶,为蚕接下来大量吐丝做准备,约第7天时,蚕体变得通透,头部变黄,将要开始吐丝,此时,需要将蚕放到可以结茧的网子里面,待蚕开始结茧作蛹,此时温度约为25℃,湿度约为85%,无需再喂食,清理蚕室,等待蚕破茧成蛾,这一期间约为7-10天,也可以在蚕蛹的第7天左右,人为破茧,挑选雌雄分开,帮助蚕从蛹期安全变为蛾子。成为蛾子后,将需要的雌雄蛾子相互自然交配产卵,也可以在交配4h后,拆对,将雌蛾放在蚕连纸的存卵圈中产卵,约24h后取出雌蛾,将蚕卵保存起来,待新一轮催青后,可周期饲养。The silkworm eggs in the greening period are disinfected with formaldehyde steam every 2-3 days, and the relative humidity of the environment where the silkworm eggs are located is 95%-100% every day. Collect silkworm ants, silkworm ants use the tenderest mulberry leaves to crush and feed, feed 4 times a day, and sleep after 2-3 days; after molting, they will be the second instar, and the corresponding mulberry leaves should be the tenderest leaves, and they can start netting every day. Silkworm excrement, feed 3-4 times a day, and then sleep for 3-4 days; after molting, it is the third instar, and the corresponding mulberry leaves are tender leaves, 1-2 times the size of the silkworm body. Feed 3 times a day, except Sand 1 time. The temperature of the silkworm room before this is preferably 26-27°C, and the relative humidity is 85-90%. , sleep after 4-5 days; it is the fourth instar after molting, and the mulberry leaves fed accordingly are large leaves, twice the size of the silkworm body, fed 3 times a day, and cleaned silkworm excrement 2 times. To prevent bacterial infection, you can start to spray norfloxacin (50μg/ml) on the mulberry leaves, the temperature is about 25°C, the relative humidity is about 85%, sleep after 5-6 days; after molting is the fifth instar, feed accordingly It can slowly change into old leaves, twice the size of the silkworm body, the temperature is about 25°C, and the relative humidity is 80-85%. It is fed for 3-4 days a day. Before the cocooning, it needs to be fed a lot of mulberry leaves to provide silkworms Next, prepare a large amount of silk spinning. On the seventh day, the body of the silkworm becomes transparent, the head turns yellow, and the silkworm is about to start spinning. At this time, the silkworm needs to be placed in a net that can cocoon, and when the silkworm starts to cocoon. The cocoon is made into a pupa. At this time, the temperature is about 25°C and the humidity is about 85%. There is no need to feed any more. Clean up the silkworm room and wait for the silkworm to break out of the cocoon and become a moth. On the left and right, the cocoons are artificially broken, and the male and female are selected and separated to help silkworms safely change from the pupa stage to moths. After becoming moths, naturally mate the required male and female moths to lay eggs. You can also disassemble the pair after 4 hours of mating, and place the female moths in the egg storage circle of silkworm paper. After about 24 hours, take out the female moths and place them on the Eggs are preserved, and after a new round of greening, they can be raised periodically.
4荧光筛选4. Fluorescence Screening
注射了质粒的蚕卵为G0代蚕卵,共计注射251只蚕卵,饲养至蚕蛾期共获得实验组蚕蛾48只,其中雌性蛾子20只,雄性蛾子28只,将实验组雌雄蚕蛾配对制种,剩余的雄性蛾子,与未注射质粒的雌性蛾交配,得到蚕卵G1代(卵圈27个),继续催青;并对每个卵圈单独饲养,养至G1代成蛾,对G1代蚕蛾进行逐个在体视显微镜下观察,经过荧光筛选,筛出眼睛带有绿色荧光的活实验组家蚕,得雌性家蚕5只,雄性家蚕12只,将实验组家蚕雌雄相互配对制种,得蚕卵G2代(共获得4个蛾圈),继续催青,并对G2代4个蛾圈分别单独饲养,养至G2代成蛾,对G2代蚕蛾进行逐个在体视显微镜下观察,经过荧光筛选,只获得1只眼睛带有绿色荧光的雌性蚕蛾。The silkworm eggs injected with the plasmid are the G0 generation silkworm eggs. A total of 251 silkworm eggs were injected, and a total of 48 silkworm moths in the experimental group were obtained from breeding to the silkworm moth stage, including 20 female moths and 28 male moths. The male and female silkworm moths in the experimental group were paired for seed production , the remaining male moths were mated with female moths that had not been injected with the plasmid, and the G1 generation of silkworm eggs (27 egg circles) were obtained, and continued to be green; each egg circle was raised separately until the G1 generation became moths, and the G1 generation The silkworm moths were observed one by one under a stereomicroscope, and after fluorescence screening, the living experimental group silkworms with green fluorescent eyes were screened out, and 5 female silkworms and 12 male silkworms were obtained. The male and female silkworms in the experimental group were paired with each other for seed production to obtain silkworms. Eggs of the G2 generation (a total of 4 moth circles were obtained), continued to be greened, and the 4 moth circles of the G2 generation were raised separately until the G2 generation became adult moths, and the G2 generation silkworm moths were observed under a stereo microscope one by one, and after fluorescence After screening, only one female silkworm moth with green fluorescent eyes was obtained.
利用体式显微镜对转入质粒的G1、G2代蚕蛾及未转入质粒的原种蚕蛾进行观察,结果见图3。初步可以筛选眼睛带有绿色荧光的蚕蛾作为转基因蚕蛾。The G1 and G2 generation silkworm moths transferred with the plasmid and the original silkworm moths without the plasmid were observed with a stereo microscope, and the results are shown in Figure 3. Silkworm moths with green fluorescent eyes can be preliminarily screened as transgenic silkworm moths.
5转基因蚕蛾的PCR扩增测序5 PCR amplification and sequencing of transgenic silk moth
通过荧光筛选初步确定的转基因蚕蛾,在产卵后,取其部分蛾体,将其液氮研磨,按照提取家蚕基因组的方法,提取基因组,并利用引物对Fib-H-P1、Fib-H-P2,以提取的蚕蛾的基因组为模板进行PCR扩增,获得大小约3kb的条带,见图4,其中M指DNA标准分子量marker(250bp),B2指扩增的片段Fib H-GS-site。将此条带切胶直接送出测序,所用测序引物为反向PCR引物Fib-H-P2,测序结果见序列表,另见图5,其中灰色标识的部分为GS-site的碱基序列。说明Fib H-GS-site序列已经整合到家蚕的基因组上。The transgenic silkworm moths preliminarily determined by fluorescence screening, after laying eggs, took part of the moth body, ground it with liquid nitrogen, extracted the genome according to the method of extracting the silkworm genome, and used the primer pair Fib-H-P1, Fib-H- P2, using the extracted silk moth genome as a template for PCR amplification to obtain a band of about 3kb in size, as shown in Figure 4, where M refers to the DNA standard molecular weight marker (250bp), and B2 refers to the amplified fragment Fib H-GS-site . This band was cut and sent directly for sequencing. The sequencing primer used was the reverse PCR primer Fib-H-P2. The sequencing results are shown in the sequence table, see also Figure 5, where the part marked in gray is the base sequence of GS-site. It shows that the Fib H-GS-site sequence has been integrated into the genome of silkworm.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310209747.3A CN104212833A (en) | 2013-05-30 | 2013-05-30 | Novel genetically modified plasmid vector, construction method and cultivation method of silkworms containing novel recombination gene in vivo |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310209747.3A CN104212833A (en) | 2013-05-30 | 2013-05-30 | Novel genetically modified plasmid vector, construction method and cultivation method of silkworms containing novel recombination gene in vivo |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104212833A true CN104212833A (en) | 2014-12-17 |
Family
ID=52094740
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310209747.3A Pending CN104212833A (en) | 2013-05-30 | 2013-05-30 | Novel genetically modified plasmid vector, construction method and cultivation method of silkworms containing novel recombination gene in vivo |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104212833A (en) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104450782A (en) * | 2015-01-07 | 2015-03-25 | 苏州大学 | Method of preparing silkworm model of hyperproteinemia |
CN109821053A (en) * | 2019-02-28 | 2019-05-31 | 李春 | A kind of absorbable medical suture and preparation method thereof |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1350778A (en) * | 2000-10-26 | 2002-05-29 | 中国科学院上海生物化学研究所 | Method for producing non-natural silk with silkworm |
CN1807460A (en) * | 2006-02-13 | 2006-07-26 | 浙江理工大学 | Recombinant fusion protein of fibroin and RGD, and its biological synthesis method |
CN101423841A (en) * | 2008-12-05 | 2009-05-06 | 西南大学 | Method for producing cultivated silkworm novel green cocoon practical variety by using GFP protein |
WO2011146704A1 (en) * | 2010-05-20 | 2011-11-24 | Allergan, Inc. | Degradable clostridial toxins |
JP2012239436A (en) * | 2011-05-20 | 2012-12-10 | National Institute Of Agrobiological Sciences | Method for producing single-chain antibody |
-
2013
- 2013-05-30 CN CN201310209747.3A patent/CN104212833A/en active Pending
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1350778A (en) * | 2000-10-26 | 2002-05-29 | 中国科学院上海生物化学研究所 | Method for producing non-natural silk with silkworm |
CN1807460A (en) * | 2006-02-13 | 2006-07-26 | 浙江理工大学 | Recombinant fusion protein of fibroin and RGD, and its biological synthesis method |
CN101423841A (en) * | 2008-12-05 | 2009-05-06 | 西南大学 | Method for producing cultivated silkworm novel green cocoon practical variety by using GFP protein |
WO2011146704A1 (en) * | 2010-05-20 | 2011-11-24 | Allergan, Inc. | Degradable clostridial toxins |
JP2012239436A (en) * | 2011-05-20 | 2012-12-10 | National Institute Of Agrobiological Sciences | Method for producing single-chain antibody |
Non-Patent Citations (1)
Title |
---|
SANDRINE VESSILLIER等: "Latent cytokines: development of novel cleavage", 《PROTEIN ENGINEERING, DESIGN & SELECTION》, vol. 17, no. 2, 11 February 2005 (2005-02-11) * |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104450782A (en) * | 2015-01-07 | 2015-03-25 | 苏州大学 | Method of preparing silkworm model of hyperproteinemia |
CN104450782B (en) * | 2015-01-07 | 2017-01-25 | 苏州大学 | Method of preparing silkworm model of hyperproteinemia |
CN109821053A (en) * | 2019-02-28 | 2019-05-31 | 李春 | A kind of absorbable medical suture and preparation method thereof |
CN109821053B (en) * | 2019-02-28 | 2021-06-01 | 李春 | Absorbable medical suture and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US11140883B2 (en) | Gene editing of reproductive hormones to sterilize aquatic animals | |
CN102358902B (en) | Silkworm fibroin heavy-chain gene mutation sequence and mutation method and application | |
CN106222203A (en) | CRISPR/Cas technology is utilized to obtain bombyx mori silk fibroin heavy chain gene mutant and mutation method and application | |
BR102013031016A2 (en) | pesticide gene and use of it | |
CN104673815B (en) | Compound piggyBac recombinant vectors and its preparation method and application | |
CN111518831B (en) | Application of spider botryoid gland silk protein gene sequence and method for improving performance of silkworm silk | |
CN101016556A (en) | Method for cultivated silkworm transgene | |
CN106086031A (en) | Pig flesh chalone gene editing site and application thereof | |
CN111500591B (en) | Application of spider poly-adenoid fibroin gene sequence and method for improving properties of silkworm silk | |
CN105331632A (en) | Method for synthesizing secretion calcium ion binding protein through bombyx mori posterior silkgland | |
KR101510437B1 (en) | Transgenic silkworms producing red fluorescent cocoons | |
CN110257394A (en) | Silkworm Bmhsp19.9 gene is cultivating the application in the cultivated silkworm breed variety being resistant to extreme temperature | |
CN104212833A (en) | Novel genetically modified plasmid vector, construction method and cultivation method of silkworms containing novel recombination gene in vivo | |
CN110747199B (en) | Stress-resistance-related gene NF-Y in honey bee and its application | |
CN102250932B (en) | A method for controlling the pupal stage development of silkworm | |
CN109321595B (en) | A method for constructing a conditional neuritin knockin mouse model | |
JP5997772B2 (en) | Mutated sequences of silkworm fibroin heavy chain gene, and methods and applications for inducing mutations | |
KR101480153B1 (en) | Transgenic silkworms producing cocoons containing melittins antibiotic peptides | |
CN105463022B (en) | The method for synthesizing secretion latrodectus mactans traction silk-fibroin 2 using domestic natural silk gland bioreactor | |
KR101570783B1 (en) | Transgenic silkworms producing antimicrobial peptide | |
KR101634275B1 (en) | Transgenic silkworms producing blue fluorescent cocoons | |
CN105969801A (en) | Bombyx mori middle silkgland bioreactor universal plasmid for expressing T4 ligase as well as application and method of universal plasmid | |
CN102618528A (en) | Deleting system for long fragments in genome based on TALEN (transcription activator-like effector Nuclease) and ssODNs (single stranded oligonucleotides) and application thereof | |
CN101851638A (en) | A Bovine Fetal Fibroblast Containing Ipr1 Macrophage Heterogeneous Expression Vector | |
US20120054880A1 (en) | Method for enhancing production of pathogen-resistant proteins using bioreactor |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20141217 |